🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2024-519650-36-00
Completed Phase IV

Evaluation of the effect of adrenalized lidocaine with or without bicarbonate on early postoperative recovery in ambulatory hand and foot surgery with WALANT: A Single-centre prospective randomised double-blind non-inferiority study.

2024-519650-36-00 · tracked via the Priya Life Science EU tracker
Sponsor
Centre Hospitalier Universitaire De Nimes
Sponsor type
Hospital/Clinic/Other health care facility
Therapeutic area
Anesthesia and Analgesia
Decision date
02/09/2025
Enrollment target
150
Sites
France

Condition studied

Hand Surgery, Foot surgery

Investigational medicinal product(s)

BICARBONATE DE SODIUM 84% B. BRAUNsolution pour perfusionCHLORURE DE SODIUM FRESENIUS 09 %solution pour perfusionXYLOCAINE 10 mg/ml ADRENALINE 0005 mg/mlsolution injectableXYLOCAINE 10 mg/ml ADRENALINE 0005 mg/mlsolution injectable

Eligibility

Age group
18-64 years, 65+ years
Sex
Female, Male

Primary endpoint

Quality Of recovery score (QOR 15) at day 1

Endpoint detail

Complete sensory block from injection (in min), Re-injection of intraoperative local anaesthetic: yes/no., Pain score on initial injection of anaesthetic solution: Visual Numeric Scale (VNS) 0-10., Intraoperative pain score during surgery: Visual Numeric Scale (VNS) 0-10., Visual Numeric Scale (VNS) satisfaction at discharge from hospital from 0 to 10., VNS (0-10) pain score at D0, D1, D2, Quantity of analgesic taken postoperatively during the first 48 hours postoperatively, in particular weak and strong opioids, Duration of sensory-motor block release (in h)., Postoperative adverse events including haematoma, scar deunion, re-hospitalisation, surgical site infection

Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2024-519650-36-00 on CTIS ↗ ← All trials in the EU